CASI Pharmaceuticals
CASI
#9690
Rank
C$53.98 M
Marketcap
$3.48
Share price
-1.21%
Change (1 day)
-53.48%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -C$40.2 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$22.05 Million. In 2023 the company made an earning of -C$37.51 Million, an increase over its 2022 earnings that were of -C$53.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$40.2 Million7.16%
2023 -C$37.51 Million-29.55%
2022 -C$53.24 Million4.43%
2021 -C$50.98 Million-24.56%
2020 -C$67.58 Million4.74%
2019 -C$64.52 Million65.13%
2018 -C$39.08 Million155.07%
2017 -C$15.32 Million13.93%
2016 -C$13.45 Million31.18%
2015 -C$10.25 Million-72.5%
2014 -C$37.27 Million356.62%
2013 -C$8.17 Million-60.55%
2012 -C$20.69 Million218.41%
2011 -C$6.5 Million0.74%
2010 -C$6.45 Million-32.54%
2009 -C$9.57 Million-66.98%
2008 -C$28.96 Million-14.22%
2007 -C$33.76 Million7.04%
2006 -C$31.54 Million27.95%
2005 -C$24.65 Million4.51%
2004 -C$23.59 Million-15.84%
2003 -C$28.02 Million-55.29%
2002 -C$62.68 Million-34.05%
2001 -C$95.03 Million31.73%
2000 -C$72.14 Million31.56%
1999 -C$54.84 Million145.56%
1998 -C$22.34 Million76.4%
1997 -C$12.66 Million36.92%
1996 -C$9.25 Million